Valentin Atanassov, MD
Surgery · Brockton, MANPI 1811978794
Payments from drug & device makers
Across 48 payments — averaging $206.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$5K
- TELA Bio, Inc.$2K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$320
- Intuitive Surgical$229
- Acell, Inc.$157
- plus $302 from 8 others
What the payments were for
- Consulting fees$4,90050%
- Travel & lodging$2,93430%
- Food & beverage$2,06321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 6 | $5,076 |
| TELA Bio, Inc. | 9 | $1,942 |
| Medical Device Business Services, Inc. | 9 | $1,871 |
| Johnson & Johnson | 8 | $320 |
| Intuitive Surgical | 1 | $229 |
| Acell, Inc. | 4 | $157 |
| Boston Scientific | 1 | $111 |
| KCI USA, Inc. | 2 | $49 |
| TEI Biosciences Inc | 3 | $42 |
| Smith+Nephew | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $20 |
| Mesh Suture Inc | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Sanara Medtech Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ligation: Hem-o-lok Polymer Locking Ligation System$4,900
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,883
- ENSEAL Product Family$1,625
- Da Vinci Surgical System$229
- ECHELON FLEX Stapler$111
- HARMONIC Product Family$111
- SURGICEL Family of Absorbable Hemostats$111
How this compares
$9,897 in reported general payments places this provider in the 80th percentile of 694 surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 16 | $707 |
Paid to pharmacies, not to this prescriber.
Other surgery in Brockton
- Philip CohenBrockton$280K
- Monica BertagnolliBoston$155.3M
- Stephen MillerBoston$3.7M
- Michael TarnoffBoston$1.4M
- Omar KudsiBoston$991K
- Allan GoldsteinBoston$501K
- Chad WilsonBoston$363K
- Ankit MehtaBoston$307K
- Richard HodinBoston$284K
- Mark ConradMethuen$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.